The invention also simultaneously discloses the hydrophilic medicine controlled - release microspheres formulation.
本发明还同时公开了按照上述方法制备而得的亲水性药物缓释微球制剂.
互联网
Study immunological adjuvant function of biodegradable microspheres for DNA immunization.
探讨生物可降解微球对基因免疫的增强作用.
互联网
Many microspheres in the lung could be observed in the paraffin section.
各器官石蜡切片中,肺组织中有较多微球嵌顿.
互联网
OBJECTIVE To study the in vivo release of nisoldipine microspheres in rabbits.
目的:研究尼索地平微球在家兔体内的释药行为.
互联网
OBJECTIVE To optimize the preparation technique of microspheres containing dexamethasone sodium phosphate.
目的:研究水溶性药物地塞米松磷酸钠肺靶向微球制备工艺的优化.
互联网
ConclusionBlend microspheres with good performance were prepared with alginate and starch.
结论以海藻酸钠和淀粉为原料制备了性能良好的复合微球.
互联网
Adsorption to trans - aconitic acid by non - molecularly imprinted microspheres is 26.26 %.
充分验证了沉淀聚合法合成分子印迹聚合物微球是一种新的有效的分子印迹方法这一观点.
互联网
Preparation of biodegradable PELA microspheres and optimization of the technology are reported.
本文报道了可生物降解的PELA微球的优化工艺,制得平均球径为32.μ,平均包封率为75%上,临界相对湿度约78%及流动性好的白色球形粉末.
互联网
Results: The microspheres had a property of sustained drug release.
结果: 该微球具有良好缓释效果.
互联网
The laccase was immobilized on the magnetic chitosan microspheres.
以磁性壳聚糖微球为载体固定漆酶.
互联网
Matrine albumin microspheres were prepared by emulsion - chemical cross linking method.
以乳化 - 化学交联法制备苦参碱白蛋白微球.
互联网
Objective To optimize the formulation of methimazole - loaded polylactic - co - glycolic acid ( PLGA ) microspheres.
目的优化甲巯咪唑 聚乳酸 - 羟基乙酸共聚物微球的处方工艺.
互联网
The applications of hollow microspheres structure in different fields were introduced.
对空心微球结构材料在不同领域中的最新研究进展做了评述.
互联网
OBJECTIVE Polyactic acid enveloped aspirin microspheres were prepared by solvent evaporation method.
目的:用溶剂挥发法以聚乳酸为载体制得阿司匹林聚乳酸微球.
互联网
Objectivefunctional magnetic microspheres for the separation of vascular endothelial growth factor ( VEGF ) nucleic acid and lactase enzyme immobilization.
此外,固定化乳糖酶实验结果显示固定化酶的量与磁性微球的量成正比.
互联网